These effects are diminished or absent in people who are overweight or obese or who have brain insulin resistance or type 2 diabetes (as reported for brain insulin effects on peripheral insulin sensitivity [44, 55], endogenous glucose production [44, 75], peripheral glucose uptake [44], liver energy metabolism [64], liver fat content [64] and pancreatic insulin secretion [69]). Here, INS is linked to Insulin resistance.